{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:52:44Z","timestamp":1783075964718,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jpsychires.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T05:30:57Z","timestamp":1565328657000},"page":"129-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Ketamine metabolite pilot study in a suicidal depression trial"],"prefix":"10.1016","volume":"117","author":[{"given":"Michael F.","family":"Grunebaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanga C.","family":"Galfalvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Hwei","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Parris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainsley K.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Suckow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. John","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2019.08.005_bib1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","article-title":"Treatment resistant depression: a multi-scale, systems biology approach","volume":"84","author":"Akil","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.jpsychires.2019.08.005_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bph.13714","article-title":"Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus","volume":"174","author":"Ardalan","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.08.005_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation:","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.jpsychires.2019.08.005_bib6","first-page":"CD011612","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","volume":"9","author":"Caddy","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10128","key":"10.1016\/j.jpsychires.2019.08.005_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2019.08.005_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2015.01.022","article-title":"Spine synapse remodeling in the pathophysiology and treatment of depression","volume":"601","author":"Duman","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.08.005_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/npp.2013.195","article-title":"Abnormalities in white matter microstructure associated with chronic ketamine use","volume":"39","author":"Edward Roberts","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.08.005_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib11","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)","author":"First","year":"1994"},{"key":"10.1016\/j.jpsychires.2019.08.005_bib12","series-title":"Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II), (Version 2.0)","author":"First","year":"1996"},{"issue":"3","key":"10.1016\/j.jpsychires.2019.08.005_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.08.005_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.08.005_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-4159.2011.07361.x","article-title":"Potentiation of mu-opioid receptor-mediated signaling by ketamine","volume":"119","author":"Gupta","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.005_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpba.2017.02.035","article-title":"Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS\/MS in human serum, urine and fecal samples","volume":"139","author":"Hasan","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib18","series-title":"Suicide Mortality in the United States, 1999\u20132017","author":"Hedegaard","year":"2018"},{"issue":"9","key":"10.1016\/j.jpsychires.2019.08.005_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/iju.12841","article-title":"Possible pathophysiology of ketamine-related cystitis and associated treatment strategies","volume":"22","author":"Jhang","year":"2015","journal-title":"Int. J. Urol."},{"issue":"5994","key":"10.1016\/j.jpsychires.2019.08.005_bib20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2019.08.005_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","article-title":"Ketamine and the next generation of antidepressants with a rapid onset of action","volume":"123","author":"Machado-Vieira","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.08.005_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of +\u00a6-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"16","key":"10.1016\/j.jpsychires.2019.08.005_bib23","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.294.16.2064","article-title":"Suicide prevention strategies: a systematic review","volume":"294","author":"Mann","year":"2005","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib24","series-title":"Manual for the Profile of Mood States","author":"McNair","year":"1981"},{"issue":"3","key":"10.1016\/j.jpsychires.2019.08.005_bib25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2015.83","article-title":"A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder","volume":"21","author":"Milak","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2019.08.005_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.157","article-title":"The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats","volume":"3","author":"Moaddel","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"6436","key":"10.1016\/j.jpsychires.2019.08.005_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jpsychires.2019.08.005_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-006-0572-3","article-title":"Acute and chronic effects of ketamine upon human memory: a review","volume":"188","author":"Morgan","year":"2006","journal-title":"Psychopharmacology (Berlin)"},{"issue":"10","key":"10.1016\/j.jpsychires.2019.08.005_bib29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychires.2019.08.005_bib30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.08.005_bib31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"1","key":"10.1016\/j.jpsychires.2019.08.005_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ALN.0000000000000285","article-title":"(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function","volume":"121","author":"Paul","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpsychires.2019.08.005_bib33","series-title":"Antidepressant Use Among Persons Aged 12 and over: United States, 2011\u20132014","author":"Pratt","year":"2017"},{"issue":"3","key":"10.1016\/j.jpsychires.2019.08.005_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.118.251652","article-title":"Sex differences in the pharmacokinetics of low-dose ketamine in plasma and brain of male and female rats","volume":"367","author":"Saland","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.08.005_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of Mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2019.08.005_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ijnp\/pyx108","article-title":"Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: comparison with (R)-Ketamine","volume":"21","author":"Shirayama","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2019.08.005_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2019.08.005_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib39","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","author":"WHO","year":"2017"},{"issue":"12","key":"10.1016\/j.jpsychires.2019.08.005_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"7604","key":"10.1016\/j.jpsychires.2019.08.005_bib41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jpsychires.2019.08.005_bib42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2019.08.005_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.jpsychires.2019.09.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000}}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619304297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619304297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:13:25Z","timestamp":1758366805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619304297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"alternative-id":["S0022395619304297"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.005","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine metabolite pilot study in a suicidal depression trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}